Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation
- 3 May 2004
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 33 (12) , 1219-1224
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Intraperitoneal Chemotherapy for Ovarian Carcinoma: Results of Long-Term Follow-UpJournal of Clinical Oncology, 2002
- Intravenous Chemotherapy, Early Debulking Surgery, and Consolidation Intraperitoneal Chemotherapy in Advanced Ovarian CarcinomaGynecologic Oncology, 2001
- Endometriosis-Associated Ovarian Carcinoma (EAOC): An Entity Distinct from Other Ovarian Carcinomas as Suggested by a Nested Case-Control StudyGynecologic Oncology, 2001
- High-Dose Topotecan, Melphalan, and Cyclophosphamide (TMC) with Stem Cell Support: A New Regimen for the Treatment of Advanced Ovarian CancerGynecologic Oncology, 2001
- High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancerBone Marrow Transplantation, 2000
- Whole Abdominal Radiotherapy Following Second-Look Laparotomy for Ovarian CarcinomaGynecologic Oncology, 1999
- Intraperitoneal Interferon-α in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group StudyGynecologic Oncology, 1999
- Consolidation Radiotherapy after Carboplatin-Based Chemotherapy in Radically Operated Advanced Ovarian CancerGynecologic Oncology, 1999
- Long-Term Survival with Whole Abdominopelvic Irradiation in Platinum-Refractory Persistent or Recurrent Ovarian CancerGynecologic Oncology, 1997
- Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinomaGynecologic Oncology, 1992